[Dynamics of the immunodepressive and antitumor activity of adriamycin].
作者信息
Vereina T L, Turishchev V E, Gavrilova A D, Matveev A B
出版信息
Farmakol Toksikol. 1986 Jan-Feb;49(1):73-5.
PMID:3948992
Abstract
It was revealed in experiments on mice that the immunodepressive activity of adriamycin depends exponentially on the dose of the preparation and is marked both before and after the antigen stimulation. The degree of immunodepression, the kinetics of formation and attenuation of the immune response depend on the dose of adriamycin. The preparation possesses antitumoral activity in relation to the plasmacytoma MOPC-315.
摘要
相似文献
1
[Dynamics of the immunodepressive and antitumor activity of adriamycin].
Farmakol Toksikol. 1986 Jan-Feb;49(1):73-5.
2
[Antitumor and immunodepressive action of dexamethasone on a leukemia L-1210 model].[地塞米松对白血病L-1210模型的抗肿瘤及免疫抑制作用]
Farmakol Toksikol. 1979 Sep-Oct;42(5):537-41.
3
[The immunodepressive and lympholytic action of kortifen].
Farmakol Toksikol. 1988 Sep-Oct;51(5):72-4.
4
5
[Immunotropic activity of adapiprazine].[阿地哌嗪的免疫调节活性]
Farmakol Toksikol. 1977 Sep-Oct;40(5):573-8.
6
[Immunodepressant action of cyclophosphamide in different strains of mice].
Biull Eksp Biol Med. 1977 Apr;83(4):438-40.
7
Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.阿霉素治疗后小鼠针对同种异体肿瘤细胞的免疫反应发育增强。
Cancer Res. 1981 Sep;41(9 Pt 1):3370-6.
8
9
Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.荷瘤BALB/c小鼠经瘤内和腹腔注射美法仑治疗后对MOPC-315浆细胞瘤耐药性的发展。I. 联合化疗-免疫疗法增强体内排斥反应
J Natl Cancer Inst. 1982 Jun;68(6):963-9.
10
Zotero 插件